Novartis AG Common Stock (NVS)
Common Stock
$736.00M
Quarterly · Period ending: · USD
NVS Common Stock
Latest reported$736.00Mperiod ending
Latest reported$736.00Mperiod ending
NVS Quarterly Common Stock ($0.00 → $736.00M)
Quarterly common stock
High-resolution chart · PNG
NVS common stock history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Common Stock (USD) |
|---|---|
| 736,003,000 | |
| 736,000,000 | |
| 766,001,000 | |
| 766,000,000 | |
| 766,000,000 | |
| 766,000,000 | |
| 793,000,000 | |
| 793,000,000 | |
| 793,000,000 | |
| 793,000,000 | |
| 824,998,375 | |
| 825,000,000 | |
| 842,000,000 | |
| 842,000,000 | |
| 890,002,153 | |
| 890,000,000 | |
| 890,000,000 | |
| 901,000,000 | |
| 901,000,000 | |
| 901,000,000 | |
| 913,000,000 | |
| 913,000,000 | |
| 913,000,000 | |
| 913,000,000 | |
| 913,000,000 | |
| 936,000,000 | |
| 935,995,954 | |
| 936,000,000 | |
| 936,000,000 | |
| 944,000,000 | |
| 944,000,000 | |
| 944,000,000 | |
| 944,000,000 | |
| 969,000,000 | |
| 969,000,000 | |
| 72,311,000,000 | |
| 69,919,000,000 | |
| 67,586,000,000 | |
| 972,000,000 | |
| 74,984,000,000 | |
| 72,456,000,000 | |
| 71,813,000,000 | |
| 991,000,000 | |
| 76,712,000,000 | |
| 78,764,000,000 | |
| 76,376,000,000 | |
| 1,001,000,000 | |
| 71,338,000,000 | |
| 70,387,000,000 | |
| 70,210,000,000 | |
| 1,001,000,000 | |
| 72,047,000,000 | |
| 69,493,000,000 | |
| 67,029,000,000 | |
| 1,001,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 1,016,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 957,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 957,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 959,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 990,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 990,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 994,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 1,008,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 1,017,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 1,008,000,000 | |
| 0 | |
| 0 | |
| 871,000,000 | |
| 0 | |
| 880,000,000 |